Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Vanderheyden

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicineE Deutsch, K Libson, J L Vanderheyden, et al.
Fundamental & Clinical Pharmacology|August 14, 2003
Molecular characterization of the high-affinity [3H]neuropeptide Y-binding component from the venom of Conus anemoneMinh Tam Le, Patrick M L Vanderheyden, Frederik L P Fierens, et al.
The Journal of Biological Chemistry|May 15, 2002
Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N-and C-terminal residues of angiotensin II during AT1 receptor activationMinh Tam Le, Patrick M L Vanderheyden, Márta Szaszák, et al.
The International Journal of Applied Radiation and Isotopes|December 1, 1983
Preparation and characterization of [99mTc(DMPE)2X2]+, X = Cl, Br (DMPE = 1,2-bis(dimethylphosphino)ethane)J L Vanderheyden, K Libson, D L Nosco, et al.
Regulatory Peptides|March 14, 2002
Formation of angiotensin-(1-7) from angiotensin II by the venom of Conus geographusMinh Tam Le, Patrick M L Vanderheyden, Geert Baggerman, et al.
Biochemical Pharmacology|March 26, 2004
Effect of saponin and filipin on antagonist binding to AT 1 receptors in intact cellsIlse Verheijen, Dieter Tourlousse, Patrick M L Vanderheyden, et al.
Biochemical Pharmacology|September 18, 2002
Antagonist interaction with endogenous AT(1) receptors in human cell linesIlse Verheijen, Patrick M L Vanderheyden, Jean-Paul De Backer, et al.
Biochimica Et Biophysica Acta. General Subjects|March 10, 2019
Number and brightness analysis to study spatio-temporal distribution of the angiotensin II AT<sub>1</sub> and the endothelin-1 ET<sub>A</sub> receptors: Influence of ligand bindingNadir Planes, Michelle A Digman, Patrick P M L Vanderheyden, et al.
Biochemical Pharmacology|April 16, 2003
Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptorsMinh Tam Le, Patrick M L Vanderheyden, Márta Szaszák, et al.
Archiv Der Pharmazie|June 30, 2011
1-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-pyrrolidine-2-carboxamide: investigation of structural variationsAlessia Catalano, Alessia Carocci, Antonia Di Mola, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicineE Deutsch, K Libson, J L Vanderheyden, et al.
Fundamental & Clinical Pharmacology|August 14, 2003
Molecular characterization of the high-affinity [3H]neuropeptide Y-binding component from the venom of Conus anemoneMinh Tam Le, Patrick M L Vanderheyden, Frederik L P Fierens, et al.
The Journal of Biological Chemistry|May 15, 2002
Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N-and C-terminal residues of angiotensin II during AT1 receptor activationMinh Tam Le, Patrick M L Vanderheyden, Márta Szaszák, et al.
The International Journal of Applied Radiation and Isotopes|December 1, 1983
Preparation and characterization of [99mTc(DMPE)2X2]+, X = Cl, Br (DMPE = 1,2-bis(dimethylphosphino)ethane)J L Vanderheyden, K Libson, D L Nosco, et al.
Regulatory Peptides|March 14, 2002
Formation of angiotensin-(1-7) from angiotensin II by the venom of Conus geographusMinh Tam Le, Patrick M L Vanderheyden, Geert Baggerman, et al.
Biochemical Pharmacology|March 26, 2004
Effect of saponin and filipin on antagonist binding to AT 1 receptors in intact cellsIlse Verheijen, Dieter Tourlousse, Patrick M L Vanderheyden, et al.
Biochemical Pharmacology|September 18, 2002
Antagonist interaction with endogenous AT(1) receptors in human cell linesIlse Verheijen, Patrick M L Vanderheyden, Jean-Paul De Backer, et al.
Biochimica Et Biophysica Acta. General Subjects|March 10, 2019
Number and brightness analysis to study spatio-temporal distribution of the angiotensin II AT<sub>1</sub> and the endothelin-1 ET<sub>A</sub> receptors: Influence of ligand bindingNadir Planes, Michelle A Digman, Patrick P M L Vanderheyden, et al.
Biochemical Pharmacology|April 16, 2003
Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptorsMinh Tam Le, Patrick M L Vanderheyden, Márta Szaszák, et al.
Archiv Der Pharmazie|June 30, 2011
1-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-pyrrolidine-2-carboxamide: investigation of structural variationsAlessia Catalano, Alessia Carocci, Antonia Di Mola, et al.
Pageof 5